These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Winner P; Ricalde O; Le Force B; Saper J; Margul B Arch Neurol; 1996 Feb; 53(2):180-4. PubMed ID: 8639069 [TBL] [Abstract][Full Text] [Related]
3. Ergotamine, dihydroergotamine: current uses and problems. Tfelt-Hansen P Curr Med Res Opin; 2001; 17 Suppl 1():s30-4. PubMed ID: 12463275 [TBL] [Abstract][Full Text] [Related]
4. Dihydroergotamine: a review of formulation approaches for the acute treatment of migraine. Silberstein SD; Kori SH CNS Drugs; 2013 May; 27(5):385-94. PubMed ID: 23620146 [TBL] [Abstract][Full Text] [Related]
5. Innovative delivery systems for migraine: the clinical utility of a transdermal patch for the acute treatment of migraine. Rapoport AM; Freitag F; Pearlman SH CNS Drugs; 2010 Nov; 24(11):929-40. PubMed ID: 20932065 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacologic treatment of acute migraine attack in children]. Cuvellier JC; Joriot S; Auvin S; Vallée L Arch Pediatr; 2005 Mar; 12(3):316-25. PubMed ID: 15734131 [TBL] [Abstract][Full Text] [Related]
8. MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine. Aurora SK; Silberstein SD; Kori SH; Tepper SJ; Borland SW; Wang M; Dodick DW Headache; 2011 Apr; 51(4):507-17. PubMed ID: 21457235 [TBL] [Abstract][Full Text] [Related]
9. Drugs for the acute treatment of migraine in children and adolescents. Richer L; Billinghurst L; Linsdell MA; Russell K; Vandermeer B; Crumley ET; Durec T; Klassen TP; Hartling L Cochrane Database Syst Rev; 2016 Apr; 4(4):CD005220. PubMed ID: 27091010 [TBL] [Abstract][Full Text] [Related]
10. The triptan formulations : how to match patients and products. Rapoport AM; Tepper SJ; Bigal ME; Sheftell FD CNS Drugs; 2003; 17(6):431-47. PubMed ID: 12697002 [TBL] [Abstract][Full Text] [Related]
12. A review of needle-free sumatriptan injection for rapid control of migraine. Rothrock JF; Freitag FG; Farr SJ; Smith EF Headache; 2013 Sep; 53 Suppl 2():21-33. PubMed ID: 24024600 [TBL] [Abstract][Full Text] [Related]
13. Rescue therapy for acute migraine, part 1: triptans, dihydroergotamine, and magnesium. Kelley NE; Tepper DE Headache; 2012 Jan; 52(1):114-28. PubMed ID: 22211870 [TBL] [Abstract][Full Text] [Related]
14. Symptomatic treatment of migraine in children: a systematic review of medication trials. Damen L; Bruijn JK; Verhagen AP; Berger MY; Passchier J; Koes BW Pediatrics; 2005 Aug; 116(2):e295-302. PubMed ID: 16061583 [TBL] [Abstract][Full Text] [Related]
15. Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment. Dahlöf C; Maassen Van Den Brink A Headache; 2012 Apr; 52(4):707-14. PubMed ID: 22444161 [TBL] [Abstract][Full Text] [Related]
17. Acute treatment of paediatric migraine: a meta-analysis of efficacy. Silver S; Gano D; Gerretsen P J Paediatr Child Health; 2008 Jan; 44(1-2):3-9. PubMed ID: 17854415 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of a monthly coverage maximum (drug-specific quantity limit) on the 5-HT1 agonists (triptans) and dihydroergotamine nasal spray. Hoffman L; Mayzell G; Pedan A; Farrell M; Gilbert T J Manag Care Pharm; 2003; 9(4):335-45. PubMed ID: 14613452 [TBL] [Abstract][Full Text] [Related]
20. Sumatriptan : treatment across the full spectrum of migraine. Silberstein SD; Marcus DA Expert Opin Pharmacother; 2013 Aug; 14(12):1659-67. PubMed ID: 23786565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]